Back
 
  • Introduction
  • Company Strategy
  • Presentation and Events
  • Financial Highlights
  • Financial Reporting
Scroll

Upcoming Events

Investor Contact

  • +94 114731731 (Ext. 1278)
  • ir@hemas.com

Company Strategy

01

Developing a portfolio of consumer brands that delight Sri Lankan consumers

02

Tapping into the emerging Asian consumer

03

Affordable healthcare and diagnostics services

04

Serving the region’s logistics and route-to-market needs

05

Delivering quality medicines and therapies to patients who need the

06

High quality leisure experiences to upscale travelers

07

Connecting patient to excellent healthcare outcomes via digital

Events

Financial Highlights

Key Performance Indicators
As at 31 March FY 15 FY 16 FY 17 FY 18 FY 19
ROE 12.9% 14.1% 14.9% 10.4% 12.6%
Earnings per share (Rs.) 3.7 4.7 6.1 4.7 5.7
Dividend per share (Rs.) 1.1 1.1 1.4 1.9 4.9
Dividend Payout 29.4% 23.7% 23.0% 39.5% 87.3%
Net Asset Value per share (Rs.) 30.4 38.4 43.5 46.2 47.1
Market Capitalization as at March 31 (Rs. Mn) 37,977 46,147 62,256 71,809 44,703
Price to Earnings Ratio (Times) 19.7 17.1 17.8 26.7 13.3
Share Price as at 31 March (Rs.) 73.7 80.6 108.7 124.9 75.0
Gearing 26.9% 22.8% 16.0% 18.7% 18.2%